SMR | Conference

Adil Daud, MD, on the Importance of Testing Patients with Melanoma for BRAF Mutations
November 15, 2020

Adil Daud, MD, spoke about the emergence of next-generation sequencing and the importance of testing patients with melanoma for BRAF mutations.

Jeffrey Weber, MD, PhD, Describes Unmet Needs for Patients with Melanoma
November 14, 2020

Jeffrey Weber, MD, PhD, discusses the unmet needs professionals take into consideration when deciding treatment options for patients with melanoma.

Hussein Tawbi, MD, PhD, Discusses Results From the COMBI-AD Trial
November 13, 2020

Data from the COMBI-AD Trial evaluating dabrafenib and trametinib to treat melanoma was analyzed by Hussein Tawbi, MD, PhD, of The University of Texas MD Anderson Cancer Center.

Jason Luke, MD, FACP, on BRAF Mutations, Melanocytes and Melanoma Treatments
November 12, 2020

CancerNetwork spoke with Jason Luke, MD, FACP, at the SMR Conference regarding the latest updates on melanoma.

Kunal Rai, PhD, Discusses Genomic Alterations in Melanoma Therapy
November 27, 2019

The MD Anderson Cancer Center expert discussed how researchers are using genetic alterations to drive specific therapies at the 16th International Congress of the Society for Melanoma Research.

Richard White, MD, PhD, Discusses His Research into Why Melanoma Metastasizes
November 27, 2019

The Memorial Sloan Kettering Cancer Center expert discussed a study he designed to discover why and how melanoma metastasizes, at the 16th International Congress of the Society for Melanoma Research.

Sancy Leachman, MD, PhD, Discusses Her Early-Detection Outreach Effort for Melanoma
November 26, 2019

Sancy Leachman, MD, PhD, discusses her outreach effort titled “War on Melanoma” at the 16th International Congress of the Society for Melanoma Research.

Poulikos Poulikakos, PhD, on Combining Targeted Therapy and Immunotherapy in Melanoma
November 26, 2019

Poulikos Poulikakos, PhD, discussed combining targeted therapy and immunotherapy for the  treatment of patients with melanoma at the 16th International Congress of the Society for Melanoma Research.

Study Moves the Needle for Melanoma Patients with Rare BRAF Mutations
October 17, 2019

BRAF and MEK inhibitors appear to have clinical activity in patients with metastatic melanoma with rare BRAF mutations.

Incidence of Non-Melanoma Skin Cancer Tallies Biggest Change From 2016 to 2017
September 27, 2019

The Global Burden of Disease 2017 study found non-melanoma skin cancer to be the biggest increase in incidence worldwide.